Summary of risk factors for AGVHD, transplantation-related mortality, and overall mortality for SD and URD cohorts
Variable* . | AGVHD grades B-D . | AGVHD grades C-D . | Transplantation-related mortality . | Overall mortality . | ||||
---|---|---|---|---|---|---|---|---|
SD . | URD . | SD . | URD . | SD . | URD . | SD . | URD . | |
MA + TBI + PBSC | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
MA + TBI + BM | — | ↓ | — | ↓ | — | — | ↓ | — |
MA + nonTBI + PBSC | — | — | — | — | — | — | ↓ | — |
MA + nonTBI + BM | ↓ | ↓ | ↓ | ↓ | — | — | — | — |
RIC + PBSC | ↓ | ↓ | — | — | — | ↓ | — | — |
RIC + BM | — | ↓ | — | ↓ | — | — | — | — |
Tacrolimus-based GVHD prophylaxis | ↓ | ↓ | ↓ | — | ↓ | — | ↓ | — |
Older recipient age | — | — | — | — | ↑ | ↑ | ↑ | ↑ |
Older donor age | — | — | — | — | — | ↑ | — | ↑ |
Higher KPS | — | — | — | — | ↓ | ↓ | ↓ | ↓ |
Disease type other than ALL | — | ↑ | — | ↑ | ↓ | — | ↓ | ↓ |
Disease status other than early | — | — | ↑ | — | ↑ | ↑ | ↑ | ↑ |
Female donor for male recipient | — | ↑ | — | ↑ | ↑ | ↑ | — | |
CMV other than NN | — | — | — | — | — | ↑ | — | ↑ |
ABO mismatch | — | — | — | — | — | ↑ | — | ↑ |
HLA mismatch | NA | ↑ | — | ↑ | NA | ↑ | NA | ↑ |
Variable* . | AGVHD grades B-D . | AGVHD grades C-D . | Transplantation-related mortality . | Overall mortality . | ||||
---|---|---|---|---|---|---|---|---|
SD . | URD . | SD . | URD . | SD . | URD . | SD . | URD . | |
MA + TBI + PBSC | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
MA + TBI + BM | — | ↓ | — | ↓ | — | — | ↓ | — |
MA + nonTBI + PBSC | — | — | — | — | — | — | ↓ | — |
MA + nonTBI + BM | ↓ | ↓ | ↓ | ↓ | — | — | — | — |
RIC + PBSC | ↓ | ↓ | — | — | — | ↓ | — | — |
RIC + BM | — | ↓ | — | ↓ | — | — | — | — |
Tacrolimus-based GVHD prophylaxis | ↓ | ↓ | ↓ | — | ↓ | — | ↓ | — |
Older recipient age | — | — | — | — | ↑ | ↑ | ↑ | ↑ |
Older donor age | — | — | — | — | — | ↑ | — | ↑ |
Higher KPS | — | — | — | — | ↓ | ↓ | ↓ | ↓ |
Disease type other than ALL | — | ↑ | — | ↑ | ↓ | — | ↓ | ↓ |
Disease status other than early | — | — | ↑ | — | ↑ | ↑ | ↑ | ↑ |
Female donor for male recipient | — | ↑ | — | ↑ | ↑ | ↑ | — | |
CMV other than NN | — | — | — | — | — | ↑ | — | ↑ |
ABO mismatch | — | — | — | — | — | ↑ | — | ↑ |
HLA mismatch | NA | ↑ | — | ↑ | NA | ↑ | NA | ↑ |
NN indicates negative/negative serostatus; MA, myeloablative; —, no association; Ref, reference; NA, not applicable; ↑, increased risk/odd of association with outcome; and ↓, decreased risk/odd of association with outcome.
See individual tables of multivariate analyses for reference groups.